About
Pasithea Therapeutics is a biotechnology company developing therapeutics for central nervous system disorders and RASopathies, focusing on diseases such as Neurofibromatosis type 1, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and schizophrenia.
Explore Pasithea Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.